ArticleBiologia futura2025
Biosynthesis of nickel nanoparticles using Enterobacter cloacae: characterization and multifaceted applications.
Article in Biologia futura, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study describes the biosynthesis of nickel nanoparticles (Ni NPs) using gram-negative bacterium, Enterobacter cloacae. The synthesized Ni NPs were annealed at 350 °C for 3 h and characterized using various techniques. Powder X-ray diffraction analysis revealed the formation of Ni NPs with an average crystallite size of 48.78 nm. UV-Vis spectroscopy exhibited an absorption peak at 394 nm, while FTIR confirmed a peak at 416 nm. Field emission scanning electron microscopy showed the Ni NPs as a mixture uniform distribution, characterized by almost uniform spherical or hexagonal shapes. The Ni NPs demonstrated moderate antibacterial activity but exhibited notably high biofilm activity against Pseudomonas aeruginosa species, suggesting their potential in combating biofilm-associated infections. Additionally, the biosynthesized Ni NPs showed promising larvicidal and Insecticidal activities. This study provides an eco-friendly and cost-effective method for synthesizing Ni NPs and highlights their multifaceted applications in healthcare and pest control.
Indexed as
Identifiers
40014288What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.